Form 4 Tracker
Enliven Therapeutics, Inc.
ELVN

27 insider filings · Latest: Jun 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 14, 2025Apr 14 8:54 PMPatel Anish
Proposed Sale
2,010$16.51$33.2K

View →

Apr 14, 2025Apr 14 8:48 PMPatel Anish
Proposed Sale
2,010$16.51$33.2K

View →

Apr 7, 2025Apr 7 8:09 PMPatel Anish
Proposed Sale
6,667$18.69$124.6K

View →

Mar 27, 2025Mar 27 8:01 PMHohl Benjamin
Proposed Sale
4,250$20.58$87.5K

View →

Mar 19, 2025Mar 19 8:18 PMLyssikatos Joseph P
Proposed Sale
12,500$20.28$253.5K

View →

Mar 18, 2025Mar 18 9:33 PMKintz Samuel
Proposed Sale
21,531$21.04$453.0K

View →

Mar 18, 2025Mar 18 9:22 PMKintz Samuel
Proposed Sale
21,531$21.04$453.0K

View →

Mar 18, 2025Mar 18 8:14 PMKintz Samuel
Proposed Sale
21,531$21.04$453.0K

View →

Mar 18, 2025Mar 18 8:06 PMKintz Samuel
Proposed Sale
21,531$21.04$453.0K

View →

Mar 17, 2025Mar 17 8:14 PMKintz Samuel
Proposed Sale
12,500$20.74$259.3K

View →

Mar 17, 2025Mar 17 8:08 PMPatel Anish
Proposed Sale
2,500$20.74$51.9K

View →

Mar 17, 2025Mar 17 8:04 PMPatel Anish
Proposed Sale
2,500$20.74$51.9K

View →

Mar 7, 2025Mar 7 9:18 PMPatel Anish
Proposed Sale
6,667$21.46$143.1K

View →

Feb 27, 2025Feb 27 9:10 PMHohl Benjamin
Proposed Sale
4,250$20.28$86.2K

View →

Feb 14, 2025Feb 14 10:02 PMPatel Anish
Proposed Sale
2,500$21.50$53.8K

View →

Feb 14, 2025Feb 14 9:17 PMPatel Anish
Proposed Sale
2,500$21.50$53.8K

View →

Feb 7, 2025Feb 7 9:02 PMPatel Anish
Proposed Sale
6,667$22.47$149.8K

View →

Jan 27, 2025Jan 27 9:37 PMHohl Benjamin
Proposed Sale
4,250$21.86$92.9K

View →

Jan 14, 2025Jan 14 9:06 PMPatel Anish
Proposed Sale
2,500$22.07$55.2K

View →

Jan 14, 2025Jan 14 9:01 PMPatel Anish
Proposed Sale
2,500$22.07$55.2K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 17, 2026Jun 22 9:13 PMBenjamin HohlCHIEF FINANCIAL OFFICER
Option Exercise
6,018$2.4886,038(D)

View →

Jun 17, 2026Jun 22 9:11 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48121,268(D)

View →

May 18, 2026May 20 8:18 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48126,268(D)

View →

Apr 17, 2026Apr 22 12:40 AMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48131,268(D)

View →

Mar 25, 2026Mar 27 8:57 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
40,000$2.48136,268(D)

View →

Mar 17, 2026Mar 19 9:50 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48176,268(D)

View →

Mar 10, 2026Mar 11 9:32 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
10,129$2.48181,268(D)

View →

Mar 9, 2026Mar 11 9:32 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
29,871$2.48191,397(D)

View →

Feb 17, 2026Feb 19 11:36 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
45,000$2.48221,268(D)

View →

Feb 12, 2026Feb 18 1:01 AMLori Anne KunkelDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 1:00 AMRichard A. HeymanDirector
Grant/Award
19,234$27.1619,234(D)

View →

Feb 12, 2026Feb 18 12:59 AMRishi GuptaDirector
Grant/Award
35,569$27.161,580(D)

View →

Feb 12, 2026Feb 18 12:57 AMScott J. GarlandDirector
Grant/Award
1,427$27.161,427(D)

View →

Feb 12, 2026Feb 18 12:56 AMMika K DerynckDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 12:56 AMJake BauerDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 12:55 AMRahul D. BallalDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 12:53 AMAnish PatelCHIEF OPERATING OFFICER
Grant/Award
120,000$27.16120,000(D)

View →

Feb 12, 2026Feb 18 12:52 AMJoseph P LyssikatosCHIEF SCIENTIFIC OFFICER
Grant/Award
112,500$27.16112,500(D)

View →

Feb 12, 2026Feb 18 12:49 AMBenjamin HohlCHIEF FINANCIAL OFFICER
Grant/Award
150,000$27.16150,000(D)

View →

Feb 12, 2026Feb 18 12:47 AMHelen Louise CollinsCHIEF MEDICAL OFFICER
Grant/Award
150,000$27.16150,000(D)

View →